We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging

Article   Jan 16, 2020 | By Molly Campbell, Science Writer, Technology Networks

 
Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging

Brightfield microscopy images of senescent lung fibroblasts (left) and senescent renal epithelial cells (right). Blue staining of the cells is an indicator of senescence-associated beta-galactosidase activity, a marker present only on senescent cells. Credit: Nathan Basisty, PhD.

 
 
Advertisement
 

RELATED ARTICLES

Regulating Heavy Metals in Cannabis: What Can Be Learned From the Pharmaceutical Industry? Part 1

Article

This article is the first part in a series on the importance of measuring heavy metals in cannabis and hemp. In particular, the series will explore how the cannabis industry can learn a great deal from the pharmaceutical industry, which took over 20 years to bring in meaningful and comprehensive regulations for elemental impurities to ensure the safety and efficacy of drug products.

READ MORE

Sniffing Out New Methods for In-Field Pesticide Detection

Article

This article addresses the issues associated with the global use of pesticides, and some ways in which these can be overcome.

READ MORE

Diverse Opinions to Common Challenges in the Field of Metabolomics

Article

The diverse nature of the metabolome continually challenges researchers and creates a colorful array of opinions on which is the most comprehensive and precise approach, explored in this article.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE